Risk factors for respiratory Aspergillus fumigatus in German Cystic Fibrosis patients and impact on lung function.

Autor: Düesberg U; Mukoviszidose Institute, In den Dauen 6, 53117, Bonn, Germany., Wosniok J; Interdisciplinary Center Clinical Trials (IZKS), University Medical Center Mainz, Langenbeckstraße 1, Mainz, Germany., Naehrlich L; Department of Pediatrics, Justus-Liebig-University Giessen, Feulgenstr. 10-12, 35392, Giessen, Germany., Eschenhagen P; Department of Pediatric Pneumology, Immunology and Intensive Care Medicine, Cystic Fibrosis Center, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany., Schwarz C; Department of Pediatric Pneumology, Immunology and Intensive Care Medicine, Cystic Fibrosis Center, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. carsten.schwarz@charite.de.
Jazyk: angličtina
Zdroj: Scientific reports [Sci Rep] 2020 Nov 04; Vol. 10 (1), pp. 18999. Date of Electronic Publication: 2020 Nov 04.
DOI: 10.1038/s41598-020-75886-w
Abstrakt: Airway inflammation and chronic lung infections in cystic fibrosis (CF) patients are mostly caused by bacteria, e.g. Pseudomonas aeruginosa (PA). The role of fungi in the CF lung is still not well elucidated, but evidence for a harmful and complex role is getting stronger. The most common filamentous fungus in CF is Aspergillus fumigatus (AF). Age and continuous antibiotic treatment have been discussed as risk factors for AF colonisation but did not differentiate between transient and persistent AF colonisation. Also, the impact of co-colonisation of PA and AF on lung function is still under investigation. Data from patients with CF registered in the German Cystic Fibrosis Registry database in 2016 and 2017 were retrospectively analysed, involving descriptive and multivariate analysis to assess risk factors for transient or persistent AF colonisation. Age represented an independent risk factor for persistent AF colonisation. Prevalence was low in children less than ten years, highest in the middle age and getting lower in higher age (≥ 50 years). Continuous antibiotic lung treatment was significantly associated with AF prevalence in all age groups. CF patients with chronic PA infection had a lower lung function (FEV1%predicted), which was not influenced by an additional AF colonisation. AF colonisation without chronic PA infection, however, was significantly associated with a lower function, too. Older age up to 49 years and continuous antibiotic use were found to be the main risk factors for AF permanent colonisation. AF might be associated with decrease of lung function if not disguised by chronic PA infection.
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje